Eduardo Bravo

USPTO Granted Patents = 3 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

2 out of 1,178

Takeda Pharmaceutical Company Limited

Years Active: 2019-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12213998 - Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease (2025-02-04),

2. 11273182 - Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease (2022-03-15),

3. 10357518 - Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease (2019-07-23),

Title: Eduardo Bravo: Pioneering Inventor from Madrid

Introduction: Eduardo Bravo is a distinguished inventor hailing from Madrid, Spain, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Eduardo Bravo holds several recent patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Eduardo Bravo has established himself as a visionary inventor with a keen focus on developing solutions that address pressing global challenges.

Collaborations: Throughout his career, Eduardo Bravo has collaborated with leading research institutions, universities, and multinational companies to bring his innovative ideas to life and make a meaningful impact on society.

Conclusion: Eduardo Bravo's relentless passion for innovation and his commitment to creating a better world through his inventions make him a true pioneer in the field of inventing.

This text is generated by artificial intelligence and may not be accurate.